Intrauterine Spiral Can Reduce The Severity Of Menstrual Bleeding.
Women with disconsolate menstrual bleeding may manage some bas-relief using an intrauterine device, or IUD, containing the hormone levonorgestrel, according to reborn research. British researchers found that the treated IUD was more efficacious at reducing the effects of heavy menstrual bleeding (also called menorrhagia) on grandeur of life compared to other treatments vigrx in baku. Normally hand-me-down for contraception, the intrauterine system is sold under the tag name Mirena.
So "If women suffer with unmanageable periods and do not want to get pregnant - as the levonorgestrel intrauterine structure is a contraceptive - then having the levonorgestrel intrauterine system is a very obedient first-line treatment option that does not require taking regular, daily verbal medications," said the study's lead author, Dr Janesh Gupta, professor of obstetrics and gynecology at the University of Birmingham and Birmingham Women's Hospital in England tablet. For women who do want to get fertile taking the blood-clotting narcotic tranexamic acid during periods is an succeed routine of treating heavy periods.
Results of the study, which was funded by the United Kingdom's National Institute of Health Research, appear in the Jan 10, 2013 offspring of the New England Journal of Medicine. Heavy menstrual bleeding is a significant difficult for many women. About 20 percent of gynecologist organization visits in the United States and the United Kingdom are because of dense bleeding doctor. There are several nonhormonal and hormonal remedying options convenient to reduce blood loss.
The modish study compared the use of traditional medical options - tranexamic acid pills, mefenamic acid (Ponstel), combined estrogen-progestogen and progesterone by oneself - to the use of the levonorgestrel intrauterine system. The researchers randomly assigned nearly 600 women with forceful menstrual bleeding to welcome either the IUD or guideline medical care. They assessed repair using a patient-reported score on a lamella designed to measure severity of symptoms. The scale goes from 0 to 100, with cut scores indicating more severe symptoms.